{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "18627377", "DateCompleted": {"Year": "2008", "Month": "11", "Day": "28"}, "DateRevised": {"Year": "2024", "Month": "06", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2008", "Month": "07", "Day": "10"}], "Language": ["eng"], "ELocationID": ["10.1111/j.1349-7006.2008.00899.x"], "Journal": {"ISSN": "1349-7006", "JournalIssue": {"Volume": "99", "Issue": "9", "PubDate": {"Year": "2008", "Month": "Sep"}}, "Title": "Cancer science", "ISOAbbreviation": "Cancer Sci"}, "ArticleTitle": "Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo.", "Pagination": {"StartPage": "1793", "EndPage": "1797", "MedlinePgn": "1793-7"}, "Abstract": {"AbstractText": ["Cucurbitacins are a group of diverse triterpenoid substances isolated from plants with medicinal properties. One particularly potent family member is cucurbitacin B (CuB). The antiproliferative effects of CuB against human breast cancer cells were tested. Six human breast cancer cell lines were examined because they represent a diverse mix of breast cancer subtypes varying in expression of estrogen receptor (ER), Her2/neu, and p53 mutation. The antiproliferative effect of CuB were also studied in vivo. The effective dose inhibiting 50% growth (ED(50)) was between 10(-8) M and 10(-7) M for this collection of breast cancer cell lines. These cells underwent rapid morphologic changes after 15-20 min exposure to CuB (5 x 10(-7) M), which was associated with disruption of the microtubules and F-actin, as observed by confocal microscopy. Human MDA-MB-231 (ER-, p53 mutated) breast cancer cells were orthotopically implanted into the breasts of nude mice who intraperitoneally received either CuB 1.0 mg/kg or vehicle. Tumor volume was reduced by 55% in the group that received CuB for 6 weeks compared with vehicle controls. No apparent organ tissue damage was observed by pathological assessment. Interestingly, the experimental mice had lower serum glucose levels, consistent with use of CuB as an antidiabetic drug in China. This drug appears to be a third in a family of drugs targeting the microtubules (taxanes [e.g. taxol], vinca alkaloid [e.g. vincristine], and now CuB). Our in vitro and in vivo results suggest that CuB may be an effective, new approach for the treatment of ER-, Her2/neu amplified, and p53 mutant breast cancers."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Hematology/Oncology, Cedars-Sinai Medical Center/University of California at Los Angeles, School of Medicine, California 90048, USA. wakimoto@remus.dti.ne.jp"}], "Identifier": [], "LastName": "Wakimoto", "ForeName": "Naoki", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yin", "ForeName": "Dong", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "O'Kelly", "ForeName": "James", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Haritunians", "ForeName": "Talin", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Karlan", "ForeName": "Beth", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Said", "ForeName": "Jonathan", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Xing", "ForeName": "Hongtao", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Koeffler", "ForeName": "H Phillip", "Initials": "HP"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Cancer Sci", "NlmUniqueID": "101168776", "ISSNLinking": "1347-9032"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Triterpenes"}, {"RegistryNumber": "0115W5MABF", "NameOfSubstance": "cucurbitacin B"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug effects"], "DescriptorName": "Microtubules"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Triterpenes"}], "CoiStatement": "The authors have a joint research grant from CK Life Sciences International Inc., Hong Kong."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Chen JC, Chiu MH, Nie RL, Cordell GA, Qiu SX. Cucurbitacins and cucurbitane glycosides structures and biological activities. Nat Prod Rep 2005; 22: 386\u201399.", "ArticleIdList": ["16010347"]}, {"Citation": "Oh H, Mun YJ, Im SJ et\u00a0al . Cucurbitacins from Trichosanthes kirilowii as the inhibitory components on tyrosinase activity and melanin synthesis of B16/F10 melanoma cells. Planta Med 2002; 68: 832\u20133.", "ArticleIdList": ["12357397"]}, {"Citation": "Jayaprakasam B, Seeram NP, Nair MG. Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana . Cancer Lett 2003; 189: 11\u20136.", "ArticleIdList": ["12445672"]}, {"Citation": "Blaskovich MA, Sun J, Cantor A. Discovery of JSI\u2010124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 2003; 63: 1270\u20139.", "ArticleIdList": ["12649187"]}, {"Citation": "Peters RR, Baier Krepsky P, Siqueira\u2010Junior JM et\u00a0al . Nitric oxide and cyclooxygenase may participate in the analgesic and anti\u2010inflammatory effect of the cucurbitacins fraction from Wilbrandia ebracteata . Life Sci 2003; 73: 2185\u201397.", "ArticleIdList": ["12927589"]}, {"Citation": "Agil A, Miro M, Jimenez J et\u00a0al . Isolation of ani\u2010hepatotoxic principle form the juice of Ecballium elaterium . Planta Med 1999; 65: 673\u20135.", "ArticleIdList": ["15609462"]}, {"Citation": "Peters RR, Saleh TF, Lora M et\u00a0al . Anti\u2010inflammatory effects of the products from Wilbrandia ebracteata on carrageenan\u2010induced pleurisy in mice. Life Sci 1999; 64: 2429\u201337.", "ArticleIdList": ["10403502"]}, {"Citation": "Peters RR, Farias MR, Ribeiro\u2010do\u2010Valle RM. Anti\u2010inflammatory and analgesic effects of cucurbitacins from Wilbrandia ebracteata . Planta Med 1997; 63: 525\u20138.", "ArticleIdList": ["9434604"]}, {"Citation": "Duncan KLK, Duncan MD, Alley MC, Sausville A. Cucurbitacin E\u2010induced disruption of the actin and vimentin cytoskeleton in prostate carcinoma cells. Biochem Pharmacol 1996; 52: 1553\u201360.", "ArticleIdList": ["8937470"]}, {"Citation": "Yesilada E, Tanaka S, Sezik E, Tabata M. Isolation of an anti\u2010inflammatory principle from the fruit juice of Ecballium elaterium . J Nat Prod 1988; 51: 504\u20138.", "ArticleIdList": ["3404148"]}, {"Citation": "Sun J, Blaskovich MA, Jove R, Livingston SK, Coppola D, Sebti SM. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 2005; 24: 3236\u201345.", "ArticleIdList": ["15735720"]}, {"Citation": "Xia X, Hou F, Li J, Ke Y, Nie H. Two novel proteins bind specifically to trichosantin on chriocarcinoma cell membrane. J Biochem (Tokyo) 2006; 139: 725\u201331.", "ArticleIdList": ["16672273"]}, {"Citation": "Farias MR, Schenkel EP, Mayer R, R\u00fccker G. Cucurbitacins as constituents of Wilbrandia ebracteata . Planta Med 1993; 59: 272\u20135.", "ArticleIdList": ["17235971"]}, {"Citation": "Christine R, Sylvie R, Erik B et\u00a0al . Implication of STAT3 signaling in human colonic cancer cells during intestinal trefoil factor 3 (TFF3) \u2013 and vascular endothelial growth factor \u2013 mediated cellular invasion and tumor growth. Cancer Res 2005; 65: 195\u2013202.", "ArticleIdList": ["15665295"]}, {"Citation": "Duncan MD, Duncan KL. Cucurbitacin E targets proliferating endothelia. J Surg Res 1997; 69: 55\u201360.", "ArticleIdList": ["9202647"]}, {"Citation": "Yang L, Wu S, Zhang Q, Liu F, Wu P. 23,24\u2010Dihydrocucurbitacin B induces G2/M cell\u2010cycle arrest and mitochondria\u2010dependent apoptosis in human breast cancer cells (Bcap37). Cancer Lett 2007; 256: 267\u201378.", "ArticleIdList": ["17681423"]}, {"Citation": "Rowinsky EK, Donehower RC, Jones RJ, Tucker RW. Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res 1988; 48: 4093\u2013100.", "ArticleIdList": ["2898289"]}, {"Citation": "Amos LA, Lowe J. How Taxol stabilizes microtubule structure. Chem Biol 1999; 6: R65\u20139.", "ArticleIdList": ["10074470"]}, {"Citation": "Malawista SE, Sato H, Bensch KG. Vinblastine and griseofulvin reversibly disrupt the living mitotic spindle. Science 1968; 160: 770\u20132.", "ArticleIdList": ["5689568"]}, {"Citation": "Jordan MA, Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 1998; 10: 123\u201330.", "ArticleIdList": ["9484604"]}]}], "History": [{"Year": "2008", "Month": "7", "Day": "17", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "12", "Day": "17", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "7", "Day": "17", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "7", "Day": "10"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18627377", "PMC11159161", "10.1111/j.1349-7006.2008.00899.x", "CAS899"]}}], "PubmedBookArticle": []}